32
Participants
Start Date
November 30, 2015
Primary Completion Date
July 31, 2018
Study Completion Date
September 30, 2018
Dapagliflozin
Dapagliflozin 10 mg, orally once daily at any time of day with or without food. If HbA1c does not decrease by \> 0.4% at 12 week, rescue therapy (sitagliptin 100 mg) can be added at investigator's discretion.
Gliclazide
Gliclazide MR 30 mg, orally once daily at any time of day with or without food. If HbA1c does not decrease by \> 0.4% at 12 week, rescue therapy (gliclazide MR 30 mg) can be added at investigator's discretion.
Seoul National University Bundang Hospital, Seongnam-si
Seoul National University Bundang Hospital
OTHER